Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on October 22, 2020. The report details the entry into a material definitive agreement regarding director compensation following the company's 2020 annual stockholders meeting.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the specific director compensation package:
- Restricted Stock Grant: 15,000 shares of Class B common stock per director at a purchase price of $0.01 per share.
- Stock Option Grant: 20,000 options per director with an exercise price of $1.90 per share (based on the closing price on the Grant Date).
- Cash Compensation: $7,500 per quarter per non-employee director for annual service.
Material Changes
The material change reported is the execution of new compensation agreements for the Board of Directors under the 2012 Stock Incentive Plan. This represents a new obligation for equity and cash compensation effective as of the Grant Date.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of general risks. The vesting of the granted equity is contingent upon continued service on the Board of Directors:
- 50% of restricted stock and options vest on September 26, 2021.
- 50% of restricted stock and options vest on September 26, 2022.
- Full vesting occurs immediately upon a Change in Control.
Important Facts for Investors
- Directors received a mix of equity (restricted stock and options) and cash compensation for the 2020 service year.
- The option exercise price of $1.90 reflects the market price on October 22, 2020.
- Equity awards are subject to a two-year vesting schedule tied to continued board service.
- This filing does not contain updated financial results or operational metrics for the company.